Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD

Nrupen A. Bhavsar, Lawrence J. Appel, John W. Kusek, Gabriel Contreras, George Bakris, Josef Coresh, Brad C. Astor

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Identification of persons with chronic kidney disease (CKD) who are at highest risk to progress to end-stage renal disease (ESRD) is necessary to reduce the burden of kidney failure. The relative utility of traditional markers of kidney function, including estimated glomerular filtration rate (eGFR) and serum creatinine level, and emerging markers of kidney function, including cystatin C and beta-trace protein (BTP) levels, to predict ESRD and mortality has yet to be established. Study Design: Randomized clinical trial followed by an observational cohort study. Setting & Participants: 865 African American individuals with hypertensive CKD enrolled in a clinical trial of 2 levels of blood pressure control and 3 different antihypertensive drugs as initial therapy and subsequently followed by an observational cohort study. Predictors: Quintile of measured GFR (mGFR) by iothalamate clearance, serum creatinine, serum creatininebased eGFR, cystatin C, and BTP values. Outcomes & Measurements: Incidence of ESRD and mortality. Results: 246 participants reached ESRD during a median follow-up of 102 months. The incidence rate of ESRD was higher with higher quintiles of each marker. The association between higher BTP level and ESRD was stronger than those for the other markers, including mGFR. All markers remained significantly associated with ESRD after adjustment for mGFR and relevant covariates (all P < 0.05), with BTP level retaining the strongest association (HR for highest vs lowest quintile, 5.7; 95% CI, 2.2-14.9). Associations with the combined end point of ESRD or mortality (n = 390) were weaker, but remained significant for cystatin C (P = 0.05) and BTP levels (P = 0.004). Limitations: The ability of these markers to predict ESRD and mortality in other racial and ethnic groups and in individuals with CKD due to other causes is unknown. Conclusions: Plasma BTP and cystatin C levels may be useful adjuncts to serum creatinine level and mGFR in evaluating risk of progression of kidney disease.

Original languageEnglish
Pages (from-to)886-893
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume58
Issue number6
DOIs
StatePublished - Dec 1 2011

Fingerprint

prostaglandin R2 D-isomerase
Cystatin C
Chronic Renal Insufficiency
African Americans
Chronic Kidney Failure
Creatinine
Serum
Mortality
Glomerular Filtration Rate
Observational Studies
Cohort Studies
Iothalamic Acid
Kidney
Incidence
Kidney Diseases
Protein C
Ethnic Groups

Keywords

  • beta trace protein
  • cystatin C
  • End-stage renal disease
  • iothalamate glomerular filtration rate
  • serum creatinine

ASJC Scopus subject areas

  • Nephrology

Cite this

Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. / Bhavsar, Nrupen A.; Appel, Lawrence J.; Kusek, John W.; Contreras, Gabriel; Bakris, George; Coresh, Josef; Astor, Brad C.

In: American Journal of Kidney Diseases, Vol. 58, No. 6, 01.12.2011, p. 886-893.

Research output: Contribution to journalArticle

Bhavsar, Nrupen A. ; Appel, Lawrence J. ; Kusek, John W. ; Contreras, Gabriel ; Bakris, George ; Coresh, Josef ; Astor, Brad C. / Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. In: American Journal of Kidney Diseases. 2011 ; Vol. 58, No. 6. pp. 886-893.
@article{4b1a49f834314198bf6b28e9159ede2e,
title = "Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD",
abstract = "Background: Identification of persons with chronic kidney disease (CKD) who are at highest risk to progress to end-stage renal disease (ESRD) is necessary to reduce the burden of kidney failure. The relative utility of traditional markers of kidney function, including estimated glomerular filtration rate (eGFR) and serum creatinine level, and emerging markers of kidney function, including cystatin C and beta-trace protein (BTP) levels, to predict ESRD and mortality has yet to be established. Study Design: Randomized clinical trial followed by an observational cohort study. Setting & Participants: 865 African American individuals with hypertensive CKD enrolled in a clinical trial of 2 levels of blood pressure control and 3 different antihypertensive drugs as initial therapy and subsequently followed by an observational cohort study. Predictors: Quintile of measured GFR (mGFR) by iothalamate clearance, serum creatinine, serum creatininebased eGFR, cystatin C, and BTP values. Outcomes & Measurements: Incidence of ESRD and mortality. Results: 246 participants reached ESRD during a median follow-up of 102 months. The incidence rate of ESRD was higher with higher quintiles of each marker. The association between higher BTP level and ESRD was stronger than those for the other markers, including mGFR. All markers remained significantly associated with ESRD after adjustment for mGFR and relevant covariates (all P < 0.05), with BTP level retaining the strongest association (HR for highest vs lowest quintile, 5.7; 95{\%} CI, 2.2-14.9). Associations with the combined end point of ESRD or mortality (n = 390) were weaker, but remained significant for cystatin C (P = 0.05) and BTP levels (P = 0.004). Limitations: The ability of these markers to predict ESRD and mortality in other racial and ethnic groups and in individuals with CKD due to other causes is unknown. Conclusions: Plasma BTP and cystatin C levels may be useful adjuncts to serum creatinine level and mGFR in evaluating risk of progression of kidney disease.",
keywords = "beta trace protein, cystatin C, End-stage renal disease, iothalamate glomerular filtration rate, serum creatinine",
author = "Bhavsar, {Nrupen A.} and Appel, {Lawrence J.} and Kusek, {John W.} and Gabriel Contreras and George Bakris and Josef Coresh and Astor, {Brad C.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1053/j.ajkd.2011.07.018",
language = "English",
volume = "58",
pages = "886--893",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD

AU - Bhavsar, Nrupen A.

AU - Appel, Lawrence J.

AU - Kusek, John W.

AU - Contreras, Gabriel

AU - Bakris, George

AU - Coresh, Josef

AU - Astor, Brad C.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Background: Identification of persons with chronic kidney disease (CKD) who are at highest risk to progress to end-stage renal disease (ESRD) is necessary to reduce the burden of kidney failure. The relative utility of traditional markers of kidney function, including estimated glomerular filtration rate (eGFR) and serum creatinine level, and emerging markers of kidney function, including cystatin C and beta-trace protein (BTP) levels, to predict ESRD and mortality has yet to be established. Study Design: Randomized clinical trial followed by an observational cohort study. Setting & Participants: 865 African American individuals with hypertensive CKD enrolled in a clinical trial of 2 levels of blood pressure control and 3 different antihypertensive drugs as initial therapy and subsequently followed by an observational cohort study. Predictors: Quintile of measured GFR (mGFR) by iothalamate clearance, serum creatinine, serum creatininebased eGFR, cystatin C, and BTP values. Outcomes & Measurements: Incidence of ESRD and mortality. Results: 246 participants reached ESRD during a median follow-up of 102 months. The incidence rate of ESRD was higher with higher quintiles of each marker. The association between higher BTP level and ESRD was stronger than those for the other markers, including mGFR. All markers remained significantly associated with ESRD after adjustment for mGFR and relevant covariates (all P < 0.05), with BTP level retaining the strongest association (HR for highest vs lowest quintile, 5.7; 95% CI, 2.2-14.9). Associations with the combined end point of ESRD or mortality (n = 390) were weaker, but remained significant for cystatin C (P = 0.05) and BTP levels (P = 0.004). Limitations: The ability of these markers to predict ESRD and mortality in other racial and ethnic groups and in individuals with CKD due to other causes is unknown. Conclusions: Plasma BTP and cystatin C levels may be useful adjuncts to serum creatinine level and mGFR in evaluating risk of progression of kidney disease.

AB - Background: Identification of persons with chronic kidney disease (CKD) who are at highest risk to progress to end-stage renal disease (ESRD) is necessary to reduce the burden of kidney failure. The relative utility of traditional markers of kidney function, including estimated glomerular filtration rate (eGFR) and serum creatinine level, and emerging markers of kidney function, including cystatin C and beta-trace protein (BTP) levels, to predict ESRD and mortality has yet to be established. Study Design: Randomized clinical trial followed by an observational cohort study. Setting & Participants: 865 African American individuals with hypertensive CKD enrolled in a clinical trial of 2 levels of blood pressure control and 3 different antihypertensive drugs as initial therapy and subsequently followed by an observational cohort study. Predictors: Quintile of measured GFR (mGFR) by iothalamate clearance, serum creatinine, serum creatininebased eGFR, cystatin C, and BTP values. Outcomes & Measurements: Incidence of ESRD and mortality. Results: 246 participants reached ESRD during a median follow-up of 102 months. The incidence rate of ESRD was higher with higher quintiles of each marker. The association between higher BTP level and ESRD was stronger than those for the other markers, including mGFR. All markers remained significantly associated with ESRD after adjustment for mGFR and relevant covariates (all P < 0.05), with BTP level retaining the strongest association (HR for highest vs lowest quintile, 5.7; 95% CI, 2.2-14.9). Associations with the combined end point of ESRD or mortality (n = 390) were weaker, but remained significant for cystatin C (P = 0.05) and BTP levels (P = 0.004). Limitations: The ability of these markers to predict ESRD and mortality in other racial and ethnic groups and in individuals with CKD due to other causes is unknown. Conclusions: Plasma BTP and cystatin C levels may be useful adjuncts to serum creatinine level and mGFR in evaluating risk of progression of kidney disease.

KW - beta trace protein

KW - cystatin C

KW - End-stage renal disease

KW - iothalamate glomerular filtration rate

KW - serum creatinine

UR - http://www.scopus.com/inward/record.url?scp=81755174330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81755174330&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2011.07.018

DO - 10.1053/j.ajkd.2011.07.018

M3 - Article

C2 - 21944667

AN - SCOPUS:81755174330

VL - 58

SP - 886

EP - 893

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -